0001741042-18-000002.txt : 20180517 0001741042-18-000002.hdr.sgml : 20180517 20180517162136 ACCESSION NUMBER: 0001741042-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180517 DATE AS OF CHANGE: 20180517 EFFECTIVENESS DATE: 20180517 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nutcracker Therapeutics, Inc. CENTRAL INDEX KEY: 0001741042 IRS NUMBER: 823039939 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-312704 FILM NUMBER: 18843275 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 540 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 473-8478 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 540 CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0708 D LIVE 0001741042 Nutcracker Therapeutics, Inc. 5858 HORTON STREET, SUITE 540 EMERYVILLE CA CALIFORNIA 94608 (510) 473-8478 DELAWARE None None Corporation true 2017 Igor Khandros 5858 Horton Street, Suite 540 Emeryville CA CALIFORNIA 94608 Executive Officer Director Biotechnology Decline to Disclose 06b false 2018-04-30 false true false 0 4000000 4000000 0 false 2 0 0 0 false Nutcracker Therapeutics, Inc. /s/ Igor Khandros Igor Khandros Chief Executive Officer 2018-05-17